Onxeo Competitors and Similar CompaniesClear all

Onxeo's competitors and similar companies include APEIRON Biologics, Takeda, Biocon and Shanghai Junshi Biosciences.
Onxeo
Onxeo
Onxeo is biotechnology company that develops of drugs for oncology.
APEIRON Biologics
APEIRON Biologics
APEIRON Biologics is a biotech company focused on the discovery and development of cancer immunotherapies.
Takeda
Takeda
Takeda Pharmaceutical (武田薬品工業株式会社) is a biopharmaceutical company engaged in the research, development, production, and commercialization of pharmaceutical products.
Biocon
Biocon
Biocon is a global biopharmaceutical company.
Shanghai Junshi Biosciences
Shanghai Junshi Biosciences
Shanghai Junshi Biosciences (上海君實生物醫藥科技) is a biopharmaceutical company focused on the treatment of cancer, autoimmune, and metabolic diseases.
Founding Date
Founding Date
1997
Founding Date
2005
Founding Date
1781
Founding Date
1978
Founding Date
2012
Type
Type
Public
Type
Private
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Paris, FR HQ
New York, US
Locations
Wien, AT HQ
Locations
Tokyo, JP HQ
Buenos Aires, AR
The Rocks, AU
Linz, AT
Wien, AT
Wien, AT
Lessines, BE
see more
Locations
Bengaluru, IN HQ
Bengaluru, IN
Hyderabad, IN
Visakhapatnam, IN
Dublin, IE
Kuala Lumpur, MY
Puchong, MY
see more
Locations
Shanghai, CN HQ
Employees
Employees
30
Employees
517% decrease
Employees
49,281
Employees
16,315
Employees
2,568
Valuation ($)
Valuation ($)
65 m
Valuation ($)
N/A
Valuation ($)
43.7 b
Valuation ($)
N/A
Valuation ($)
N/A

Financial

Revenue (est.)
Revenue (est.)
€1.8m (FY, 2023)
Revenue (est.)
N/A
Revenue (est.)
¥4.3t (FY, 2024)
Revenue (est.)
₹142b (FY, 2024)
Revenue (est.)
¥1.5b (FY, 2023)
Cost of goods
Cost of goods
€533k (FY, 2023)
Cost of goods
N/A
Cost of goods
¥698.7b (FY, 2024)
Cost of goods
₹50.9b (FY, 2024)
Cost of goods
¥541m (FY, 2023)
Gross profit
Gross profit
€3.9m (FY, 2023)
Gross profit
N/A
Gross profit
¥3.6t (FY, 2024)
Gross profit
₹102b (FY, 2024)
Gross profit
¥941.9m (FY, 2023)
Net income
Net income
(€20.3m) (FY, 2023)
Net income
N/A
Net income
¥144.2b (FY, 2024)
Net income
₹13b (FY, 2024)
Net income
(¥2.5b) (FY, 2023)
For sources of this data, please see the company profile

View Company Profiles

APEIRON Biologics
HQ
Wien, AT
Employees
5↓ 17% decrease

APEIRON Biologics is a biotech company focused on the discovery and development of cancer immunotherapies.

View company
Takeda
HQ
Tokyo, JP
Employees
49,281

Takeda Pharmaceutical (武田薬品工業株式会社) is a biopharmaceutical company engaged in the research, development, production, and commercialization of pharmaceutical products.

View company
Biocon
HQ
Bengaluru, IN
Employees
16,315

Biocon is a global biopharmaceutical company.

View company
Shanghai Junshi Biosciences
HQ
Shanghai, CN
Employees
2,568

Shanghai Junshi Biosciences (上海君實生物醫藥科技) is a biopharmaceutical company focused on the treatment of cancer, autoimmune, and metabolic diseases.

View company